Protective Properties of the Extract of Chrysanthemum on Patients with Ischemic Stroke
| Autor: | Congying Xu, Yanping Wang, Xudong Lu, Yufei Shen, Xin Yu, Shuxia Qian, Xiaoling Zhang, Zhuo‐ying Zhu |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Medicine (General) Article Subject Chrysanthemum Enolase Biomedical Engineering Health Informatics medicine.disease_cause Neuroprotection Gastroenterology Brain Ischemia chemistry.chemical_compound R5-920 Internal medicine medicine Medical technology Humans R855-855.5 Stroke Ischemic Stroke Plant Extracts business.industry Standard treatment Malondialdehyde medicine.disease humanities chemistry Apoptosis Surgery Dismutase business Oxidative stress Research Article Biotechnology |
| Zdroj: | Journal of Healthcare Engineering, Vol 2021 (2021) Journal of Healthcare Engineering |
| ISSN: | 2040-2295 |
| DOI: | 10.1155/2021/3637456 |
| Popis: | Investigation of the protective effect of chrysanthemum extract in ischemic strokes patients is among the challenging issues with the traditional hospital system in general and smart technology-based hospitals in particular. In this study, we have evaluated the protective effect of chrysanthemum extract on patients with ischemic stroke by detecting the severity of stroke, neuronal indexes, and oxidative stress biomarkers. For this purpose, forty-six patients with ischemic stroke were randomly divided into the control group (n = 30) and chrysanthemum group (n = 30). The control group received standard stroke treatment, and the chrysanthemum group was treated with chrysanthemum extract 400 mg/day (200 mg/day, twice/day) on the basis of standard treatment. The groups were compared the effect of saffron capsules using the National Institute of Health Stoke Scale (NIHSS), serum neuron specific enolase (NSE), S100, brain-derived neurotrophic factor (BDNF), malondialdehyde (MDA), Su-peroxide dismutase (SOD), and total antioxidant capacity (TAC ) levels, at the time of first day and fourth day after treatment. On the first day after treatment, there was no significant difference in the NIHSS score, serum NSE, S100, BDNF, MDA, SOD, and TAC levels between the chrysanthemum group and the control group ( P > 0.05 ). On the fourth day after treatment, the NIHSS, serum NSE, S100, and MDA levels were significantly reduced in the chrysanthemum group compared to the control group, while the BDNF, SOD, and TAC levels were higher ( P < 0.05 ). In addition, compared to the levels on the first day, the NIHSS, serum NSE, S100, and MDA levels were significantly reduced, and the BDNF, SOD, and TAC levels were increased in the chrysanthemum group on the fourth day ( P < 0.05 ). Chrysanthemum extract has the effects of scavenging oxygen free radicals and antioxidation and has a neuroprotective effect on ischemic stroke patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text